TOP TIERMARKET NEWSWIRE
News & sentiment

PHARMING GROUP N V ADR (PHAR) — News & AI sentiment

PHARMING GROUP N V ADR (PHAR) news roundup. 3 stories in the last 24 hours, 14 in the past week, 20 over 30 days. Average 24-hour sentiment is 57.3/100 — neutral (50 is neutral). No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
3
avg sentiment 57.3/100
7d stories
14
avg sentiment 57.6/100
30d stories
20
avg sentiment 55.7/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

PHAR news in the last 24 hours, 7 days, 30 days and 90 days

How much PHAR coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowPHAR storiesAvg AI sentimentRead
Last 24 hours357.3/100PHAR headlines →
Last 7 days1457.6/100PHAR headlines →
Last 30 days2055.7/100PHAR headlines →
Last 90 days4656.9/100PHAR headlines →

Latest stories on PHAR

Oppenheimer reiterates Pharming Group stock rating at Outperform
Investing.com Analyst Ratings58 · neutralanalyst
7h ago
Pharming (PHAR) Q3 2026 Earnings Call Transcript
The Motley Fool64 · neutralearnings
23h ago
23h ago
1d ago
Pharming reports Q3 EPS 3c, consensus 7c
The Fly34 · bearishearnings
1d ago
Why is Pharming stock climbing today?
Investing.com Markets62 · neutralgeneral
1d ago
1d ago
1d ago
6d ago
6d ago
Pharming stock jumps on Q3 revenue beat
Investing.com Markets67 · bullishearnings
6d ago
Pharming reports Q3 revenue
Seeking Alpha50 · neutralearnings
6d ago
6d ago
6d ago
Oct 14
PHAR - Pharming Group N.V. ADR Stock Price
Barchart50 · neutralgeneral
Oct 3
Sep 30
Sep 29
Pharming CEO Fabrice Chouraqui steps down
Seeking Alpha42 · neutralgeneral
Sep 29
Pharming announces CEO transition
Business Insider50 · neutralgeneral
Sep 29
Sep 25
Sep 25
Sep 25
Canaccord reiterates Pharming stock rating on positive trial data
Investing.com Analyst Ratings63 · neutralanalyst
Sep 23
Sep 22
Open PHAR in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →